On-X Life Technologies Success Story
Stretching Clinical Research Dollars Enables On-X to Continue Investing in Product Innovation.
On-X saves over $2 million in conducting the company’s prosthetic heart valve randomized-control phase IV trial and supporting safety registry.
Results
Compared to other medical device trials, the On-X project is a large study with 1,200 patients across 40 sites. Stakes were high in finding an experienced company with the software to manage, track and report on all facets of the study. Finding a CRO partner that offers all this at an affordable price was an additional challenge. On-X and their investigator teams found a data management platform that is scalable across the different research sites, easy-to-learn and use both for their staff and for investigators, and affordable. With Clinipace Worldwide, On-X has been able to manage the research internally with a team of three people – all while saving 50-60% [over $2 million] versus a traditional CRO outsourcing strategy.